uniQure N.V (NASDAQ: QURE) on Friday, plunged -6.20% from the previous trading day, before settling in for the closing price of $22.74. Within the past 52 weeks, QURE’s price has moved between $6.14 and $71.50.
A company in the Healthcare sector has dropped its sales by -9.66% annually for the last half of the decade. The company achieved an average annual earnings per share of 22.01%. With a float of $56.77 million, this company’s outstanding shares have now reached $62.17 million.
uniQure N.V (QURE) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of uniQure N.V is 7.85%, while institutional ownership is 89.82%. The most recent insider transaction that took place on Nov 06 ’25, was worth 856,881. In this transaction Director of this company sold 31,434 shares at a rate of $27.26, taking the stock ownership to the 40,145 shares. Before that another transaction happened on Nov 04 ’25, when Company’s Director sold 38,810 for $30.34, making the entire transaction worth $1,177,517. This insider now owns 20,439 shares in total.
uniQure N.V (QURE) Latest Financial update
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported -1.44 earnings per share (EPS) for the period falling under the consensus outlook (set at -0.52) by -0.92. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.77 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 22.01% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 30.26% during the next five years compared to -9.66% drop over the previous five years of trading.
uniQure N.V (NASDAQ: QURE) Trading Performance Indicators
uniQure N.V (QURE) is currently performing well based on its current performance indicators. A quick ratio of 7.12 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 83.43.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.39, a number that is poised to hit -0.91 in the next quarter and is forecasted to reach -3.19 in one year’s time.
Technical Analysis of uniQure N.V (QURE)
Let’s dig in a bit further. During the last 5-days, its volume was 3.59 million. That was better than the volume of 2.25 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 13.74%.
During the past 100 days, uniQure N.V’s (QURE) raw stochastic average was set at 15.21%, which indicates a significant increase from 7.20% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 2.08 in the past 14 days, which was lower than the 2.49 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $45.10, while its 200-day Moving Average is $22.12. However, in the short run, uniQure N.V’s stock first resistance to watch stands at $22.69. Second resistance stands at $24.05. The third major resistance level sits at $25.12. If the price goes on to break the first support level at $20.26, it is likely to go to the next support level at $19.19. The third support level lies at $17.83 if the price breaches the second support level.
uniQure N.V (NASDAQ: QURE) Key Stats
Market capitalization of the company is 1.31 billion based on 62,292K outstanding shares. Right now, sales total 27,120 K and income totals -239,560 K. The company made 3,700 K in profit during its latest quarter, and -80,530 K in sales during its previous quarter.
